Health Care · Nasdaq Stockholm · FYE 12-31 · Prices AT CLOSE 2026-07-29 (SEK) — end-of-day, never a live or intraday quote
Last SEK 36.80Day −1.08%P/E (FY) 22.3×1Y +4.3%Off 52W high −6.6%Vol (1Y) 41.6%
Daily closing price, split-adjusted to the current basis; 2.8y shown of 4,114 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
No fair-value, short-interest or ownership figures on file for CRAD-B.ST.
| P/E (FY)22.3× |
| Sales (TTM)SEK 469.0M |
| Earnings (TTM)SEK 56.4M |
| ROE18.9% |
| Net margin12.0% |
| ROIC31.4% |
| EPS growth 3Y31.2% |
| Sales growth 3Y21.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (SEK). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+15.5% |
| 1Y+4.3% |
| 3Y+29.5% |
| 5Y−41.0% |
| 10Y+203.8% |
| Since incept. (ann.)+4.4% |
Total return through 2026-07-29 · series begins 2010-01-04. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)41.6% |
| Ann. volatility (3Y)38.7% |
| Sharpe (1Y)0.30 |
| Sharpe (3Y)0.44 |
| Max drawdown (1Y)−30.8% |
| Max drawdown (3Y)−49.0% |
| Beta (3Y vs SPY)0.96 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for CRAD-B.ST.
No reported quarters on file for CRAD-B.ST.
